ASP Isotopes extends Renergen acquisition deadline to Jan 30, 2026; awaits FinSurv approval

ASP Isotopes Inc.

Longstop date for Renergen acquisition extended to Jan 30, 2026 to allow time for remaining regulatory conditions.
Remaining key condition: approval from the South African Reserve Bank's Financial Surveillance Department (FinSurv).
Previously received approvals: Competition Commission, Industrial Development Corporation of South Africa, and U.S. International Development Finance Corporation.
ASPI also extended the loan repayment date from Renergen under the Term Loan Facility Agreement to Jan 30, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.